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Abstract
Axonal regeneration is an essential condition to re-establish functional neuronal connections in the injured adult central
nervous system (CNS), but efficient regrowth of severed axons has proven to be very difficult to achieve. Although
significant progress has been made in identifying the intrinsic and extrinsic mechanisms involved, many aspects remain
unresolved. Axonal development in embryonic CNS (hippocampus) requires the obligate activation of the insulin-like
growth factor 1 receptor (IGF-1R). Based on known similarities between axonal growth in fetal compared to mature CNS, we
decided to examine the expression of the IGF-1R, using an antibody to the bgc subunit or a polyclonal anti-peptide
antibody directed to the IGF-R (C20), in an in vitro model of adult CNS axonal regeneration, namely retinal ganglion cells
(RGC) derived from adult rat retinas. Expression of both bgc and the b subunit recognized by C20 antibody were low in
freshly isolated adult RGC, but increased significantly after 4 days in vitro. As in embryonic axons, bgc was localised to distal
regions and leading growth cones in RGC. IGF-1R-bgc co-localised with activated p85 involved in the phosphatidylinositol-3
kinase (PI3K) signaling pathway, upon stimulation with IGF-1. Blocking experiments using either an antibody which
neutralises IGF-1R activation, shRNA designed against the IGF-1R sequence, or the PI3K pathway inhibitor LY294002, all
significantly reduced axon regeneration from adult RGC in vitro (,40% RGC possessed axons in controls vs 2–8% in the
different blocking studies). Finally, co-transfection of RGC with shRNA to silence IGF-1R together with a vector containing a
constitutively active form of downstream PI3K (p110), fully restored axonal outgrowth in vitro. Hence these data
demonstrate that axonal regeneration in adult CNS neurons requires re-expression and activation of IGF-1R, and targeting
this system may offer new therapeutic approaches to enhancing axonal regeneration following trauma.
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Introduction
The functional repair of the adult central nervous system (CNS)
constitutes a major challenge for modern medicine. Both
neurodegenerative diseases and traumatic injuries of the CNS
lead to the irreversible loss of cognitive and/or motor functions,
associated with permanent disabilities. A prerequisite for func-
tional recovery is axonal and dendritic regeneration in order to re-
establish neuronal connections allowing for the normal operation
of the CNS. It was formerly thought that axonal regeneration in
adult CNS was virtually impossible [1], but the present knowledge
of intrinsic [2–5] and extrinsic [6–8] factors governing axonal
regeneration and the formation of new functional synapses has
modified this view.
It has been proposed that the mechanisms involved in axonal
regeneration of the mature CNS have many features in common
with those important in CNS development [9], [10]. However,
several aspects of axonal regeneration are still unknown, especially
those concerning the regulation of new axon sprouting by
extracellular cues. After a lesion, most CNS neurons do not
regenerate axons [11], [12]. The regulation of axonal specification
and outgrowth in development by extracellular factors is
beginning to be understood. Pyramidal cells obtained from
embryonic hippocampus have become a recognized model for
examining such events in culture. A key observation is that a
particularly early event in neurons that do not yet exhibit a
discernible axon (defined as stage 2 of differentiation [13]), is the
segregation of activatable IGF-1 receptors (IGF-1R) to one single
neurite. Subsequently, phosphatidylinositol-3 kinase (PI3K) and its
product PIP3, accumulate in the distal region and growth cone of
that same neurite, together with the IGF-1R. These events are
critical for the outgrowth of the future axon [14–16]. Indeed,
designation of the axon requires activation of PI3K by IGF-1R
PLOS ONE | www.plosone.org 1 January 2013 | Volume 8 | Issue 1 | e54462
[13], [14]. A similar system is involved in regeneration of the adult
peripheral nervous system [17], [18]. In contrast there is no
published information about the possible participation of the IGF-
1R-PI3K pathway in axonal regeneration of adult mammalian
CNS neurons.
To address this question, as an experimental model we used
retinal ganglion cells (RGC), since these have been shown to
survive and regenerate neurites in vitro [19] and both IGF-1 and
IGF-1R are widely present in different retinal cells in mammals
including man [20], [21]. Our results demonstrate that the
expression of IGF-1R is significantly higher in cultured adult RGC
than in recently disaggregated adult retina cells and that the bgc
containing variant of the IGF-1R is enriched at the third distal
axon. Loss of function experiments using a blocking IGF-1R
antibody or a shRNA directed against IGF-1R, as well as
pharmacological inhibition of PI3K signaling, repressed axonal
regeneration. Co-transfection of IGF-1R-suppressed cells with a
constitutively active form of PI3K rescued the phenotype with the
outgrowth of one or more axons.
Materials and Methods
Animals
All animal procedures adhered strictly to the guidelines of the
Association for Research in Vision and Ophthalmology Statement
on the Use of Animals in Ophthalmic and Visual Research, and
were performed using approved protocols by the Board of Animal
Welfare, School of Chemical Sciences, National University of
Cordoba, Argentina.
Primary Antibodies
The following primary antibodies were used: mouse monoclonal
antibody to c-myc (Sigma) diluted 1:600; mouse monoclonal
antibody to the axonal marker Tau-1 (Calbiochem) diluted 1:600;
rabbit polyclonal antibody to bgc [22] 1:50 for immunofluores-
cence and 1:250 for Western blots; rabbit polyclonal antibody to
the neurofilament 200 kD sub-unit (NF200) (Sigma) diluted 1:600
(NF200 is expressed by RGC and horizontal cells in the retina:
[23]); rabbit monoclonal antibody to Phospho-IGF-1 Receptor
(tyr980-C14A11-Cell Signaling) diluted 1:50; goat polyclonal
antibody to IGF-1r b subunit (20C sc-713-G, Santa Cruz
Biotechnology) diluted 1:250 for Western blots and a rabbit
monoclonal antibody to phospho p85 (tyr458)/p55(Tyr199) (Cell
Signaling) diluted 1:200.
Cell Culture
Retinal cultures were prepared essentially as previously
described [19], [24], [25]. Adult Wistar rats (weighting more than
200 g) were anesthetized with CO2, killed by cervical dislocation
and the eye tissue was rapidly removed. Retinas were isolated into
fresh CO2-independent Dulbecco’s Modified Eagle’s Medium
(DMEM-CO2) (Gibco) by circumferential section of the cornea
and removal of the anterior chamber. Major blood vessels were
excised, and retinas were then chopped into small fragments,
washed in Ringer’s solution without Ca2+ or Mg2+, supplemented
with 0.1 mM EDTA, and incubated in 0.5 ml 0.2% activated
papain (Sigma Aldrich Life Sci., Saint Quentin Fallavier, France)
in the same buffer for 30 minutes at 37uC. The tissue was
dissociated by repeated gentle trituration. To enrich the suspen-
sion in RGC, we modified a protocol originally developed for
chicken retina [26]: cells were spun for 5 min at 100 g using a
bovine serum albumin (BSA) discontinuous gradient (2.5%–4%–
5%). Screening of fractions for NF200 expression showed about
40% immunopositive cells in the fraction at the 2.5%–4%
interface (data not shown). This fraction was collected, diluted
and seeded in Neurobasal A medium containing B27 supplement
(Gibco) plus 10% bovine fetal serum and penicillin-streptomycin
(10 IU/l), into 24-well tissue culture plates containing coverslips
previously coated with poly-l-lysine (2 mg/cm2 for 2 hours)
followed by laminin (1 mg/cm2 overnight; both from Sigma
Aldrich Life Sciences. Seeding was performed at an initial density
of 2.5 or 56105 cells/cm2, and cells were incubated at 37uC in a
humidified atmosphere of 5% CO2-95% air. After 24 h the
culture medium was changed to Neurobasal A medium containing
the B27 supplement without serum.
Cell Transfection
By screening fetal rat brain expression library with an anti-bgc
antibody [22] we cloned a 150-bp sequence that is essentially
identical to a segment of the published IGF-1R. The cloned
sequence encodes a peptide close to the extracellular amino
terminus of the IGF-1R b subunit. Because there is only one
known IGF-1R gene and the different receptor variants should be
generated by alternative splicing, we used a slightly modified
published siRNA sequence to suppress IGF-1R synthesis
(GCCCATGTGTGAGAAGACC; [13], [27]). A scrambled
DNA target sequence (GAACGGTCGCAGTGTACCA) was
created using the siRNA WizardTM, InvivoGen. cDNAs encoding
shRNAs were inserted in a discistronic vector pSuper.neo+GFP
(pSuper RNAi System-OligoEngine) under the control of the H1
RNAIII polymerase promoter, and the transfection marker GFP
was under the control of the PGK promoter. The resulting
plasmids were referred to as IGF-1R shRNA and scrambled
sequence RNA (ssRNA). The myc tagged, constitutively active
p110 construct was a generous gift from Dr. L. Williams [28]. The
plasmids were mixed with Lipofectamine 2000 and added to the
neurons 12 h after plating. Transfection efficiencies were from 10
to 20%.
Immunofluorescence Microscopy
Cells were fixed for 1 h at room temperature with 4% (wt/vol)
paraformaldehyde in phosphate buffered saline (PBS), pH 7.4,
containing 4% (wt/vol) sucrose. Cultures were washed with PBS,
permeabilized with 0.1% (vol/vol) Triton X-100 in PBS for 6 min,
and again washed in PBS. After labeling with a first primary
antibody (1–3 h at room temperature) and washing with PBS,
cultures were incubated with fluorescent secondary antibody
(conjugated to Alexa fluor 488, 546 or 633; 1 h at 37uC) and
washed with PBS. The same procedure was repeated for the
second and third primary and secondary antibodies. The cells
were observed with a Zeiss Pascal 5 confocal microscope or an
Olympus FV-1000 confocal spectral microscope. Images were
captured and digitized using LSM Image software. All images
were printed using Adobe PhotoShop, with digital enhancement
performed equally for all panels.
Gel Electrophoresis and Western Blot
Proteins were separated by SDS-polyacrylamide gel electro-
phoresis. The concentration of acrylamide of the resolving gel was
11%. The resolved proteins were transferred to polyvinylidene
difluoride (PVDF) membranes in Tris-glycine buffer containing
20% methanol. The membranes were first dried, washed with
Tris-buffered saline (TBS; 10 mM Tris pH 7.5, 150 mM NaCl)
and then blocked, or directly blocked for 1 h in TBS containing
5% BSA. The blots were incubated with the primary antibodies in
PBS containing 0.05% Tween 20, for 2 h at room temperature.
After washing with TBS containing 0.05% Tween 20, the
membranes were incubated with goat or donkey anti-rabbit IgG
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Figure 1. The IGF-1R b subunit is enriched at the distal-most third of the axon in adult RGC regenerating in culture. A) Western blot of
protein from total retina disaggregated cells (RC), a fraction enriched in RGC (RGCF-see methods) and the same fraction after 4 days in culture (RGCF
4DIV) detected using an anti-bgc antibody. Equal amounts of protein from the three different fractions were loaded onto each lane. Note the
increased intensity of bgc staining in the RGC 4DIV fraction. Numbers below are the O.D. (arbitrary units) +/2 s.e.m. n = 3 independent experiments.
B) Western blot prepared as in Fig. 1 A developed using a polyclonal antibody to the IGF-1R b subunit (C20-Santa Cruz Biotechnology). Note the
increased intensity of C20 staining in the RGC 4DIV fraction. C) Triple immunofluorescence micrographs of a rat adult RGC regenerating in culture
after 3 DIV showing the distribution of the RGC marker NF200 (blue, top panel), the axonal marker Tau-1 (red, second panel) and the b subunit of the
IGF-1R (bgc) (green, third panel) in adult RGC neurons regenerating in culture. The lower panel shows a merged image of the three stainings. Note
the enrichment of bgc at the distal end of the axon (arrow). Calibration bar = 20 mm.
doi:10.1371/journal.pone.0054462.g001
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DyLight 800 fluorescent dye-conjugated secondary antibody
(Pierce Biotechnology) for 1 h at room temperature (dilution
1:15000). After washing with TBS containing 0.05% Tween 20 the
blots were analyzed using a Li-COR Odyssey Infrared Imaging
System (LI-COR Biosciences) according to the manufacturers
instruction.
Statistical Analysis
All experiments were replicated at least 3x with independent
samples and data are expressed as mean values 6 S.E. Statistical
analysis was performed using a two-tailed unpaired Student’s t test
with Excel. Differences were considered significant for p,0.05.
Results
[LOOSESR]We first investigated the expression and sub-
cellular distribution of IGF-1R in adult rat RGC after 3 days in
culture. We found that the expression of bgc containing-IGF-1R
was relatively low in both total disaggregated adult retina cells and
a fraction enriched in RGC. In contrast, RGC expressed
significantly higher amounts of bgc after 4 days in culture
(Fig. 1A). A similar result was obtained using a polyclonal
antipeptide antibody to the b subunit of the IGF-1R (C20-Santa
Cruz Biotechnology-Fig. 1.B). Immunofluorescence experiments
showed that bgc was highly enriched at the distal-most third of
axons, and the growth cone of adult RGC in culture (Fig. 1C). We
next investigated the expression and distribution of phosphorylat-
ed (active) IGF-1R and the phosphorylated form of the PI3K
regulatory sub-unit p85 in adult rat RGC grown for 3 days in the
presence of high insulin (sufficient to activate both the insulin
receptor and IGF-1R), then deprived of growth factors for four
hours and challenged with 10 nM IGF-1 for 5 min. We observed
the expression of significant amounts of both active IGF-1R
(Fig. 2A) and the phosphorylated form of p85 enriched within the
distal-most third of the axon and the growth cone in RGC. To
study the likely relationship between polarized activation of the
IGF-1R and the stimulation of axonal regeneration in RGC, we
performed loss-of-function experiments by three different ap-
proaches. Addition of an IGF-1R blocking antibody prevented
axonal outgrowth in the vast majority of neurons (Fig. 3a, bottom):
whereas 40% of control neurons developed axons, only ,2% of
neurons treated with blocking antibody exhibited axons (Fig. 3b).
Secondly, using a shRNA derived from the IGF-1R sequence
which uniformly silences the expression of bgc-containing IGF-1R
[13] we observed that most of the silenced cells challenged with
IGF-1 failed to form axons (Fig. 4a). For quantitative measures, we
scored the amount of neurons exhibiting axons in cultures
transfected with a scrambled sequence RNA (ssRNA) or with
IGF-1R-targeted shRNA. Quantification showed that only about
8% of shRNA-transfected neurons formed a discernible axon
compared to 42% of controls containing ssRNA (Fig. 4b). Finally,
most cells cultured in the presence of the PI3K inhibitor
LY294002 also failed to form axons (Fig. 3a middle). As shown
in Fig. 3b, less that 3% treated neurons exhibited axons after 3
days in culture, in contrast to neurons cultured in the absence of
the PI3K inhibitor in which almost 40% cells exhibited axons.
Reduced polarization of RGC after treatments with aIR3,
LY294002 or after shRNA addition were not related to failing
neuronal health because cell viability was not significantly affected
by any of those treatments (Fig. 3 C and 4 C) Since PI3K operates
downstream of the IGF-1R, and to further eliminate possible
artefacts due to toxic or deleterious effects of transfection with the
IGF-1R shRNA, we co-transfected cells with IGF-1R shRNA and
with a cDNA encoding a myc-tagged constitutively active form of
PI3K, p110. The results showed that co-transfection completely
rescued the phenotype, with over 90% of co-transfected cells
exhibiting axon-like processes compared to 8% of cells transfected
with IGF-1R shRNA alone (Fig. 5).
Figure 2. Stimulation with IGF-1 triggers the polarized activation of the IGF-1R and PI3K in the axons of adult rat RGC regenerating
in culture. A) Triple immunofluorescence micrographs of a rat adult RGC regenerating in culture after 3 DIV showing the distribution of the RGC
marker NF200 (blue), the axonal marker Tau-1 (red) and the phosphorylated (active) form of the IGF-1R (green, pIGF-1R). Cells were cultured for 3
days, deprived of insulin for 4 h and stimulated for 5 min in control medium or medium containing 10 nM IGF-1. Note the significant activation of the
IGF-1R, especially at the distal third of the axon (arrow). B) Triple immunofluorescence micrographs of a rat adult RGC regenerating in culture after
3 DIV showing the distribution of the RGC marker NF200 (blue), the axonal marker Tau-1 (red) and the phosphorylated form of the PI3k regulatory
subunit p85 (green, p-p85). Cells were treated as described above (Fig. 1A). Note the pronounced activation of PI3K, especially within the distal axon
(arrow). Calibration bar = 20 mm.
doi:10.1371/journal.pone.0054462.g002
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Discussion
The data presented here indicate that one of the earliest events
in regeneration of adult CNS axons, exactly as in embryonic CNS
neurons, is the expression and functioning of the IGF-1R,
including the bgc containing variant. bgc is an immunochemically
distinct b subunit of IGF-1R [13], [22], highly enriched in the
distal-most third of the axon and growth cones during neuronal
differentiation ([22], [29]-For a detailed molecular description of
this subunit see Materials and Methods under Cell Transfection).
Within the developing hippocampus, passage from stage 2 of
differentiation (prior to the appearance of a discernible axon) to
stage 3 (appearance of an identifiable axon) is marked by the
segregation of activatable IGF-1R to one neurite with the
subsequent activation of PI3K, axonal specification and outgrowth
[13]. Previous results from our laboratory showed that the
sequence encoding the bgc subunit is contained within that of
the IGF-1R [13]. Thus, the bgc variant must be the result of
alternative splicing of the single igf-1 receptor gene known to exist
in rats.
Several studies have demonstrated the involvement of IGF-1R
and downstream signaling pathways, including PI3K and cdc42,
in the regulation of axonal specification and outgrowth during
differentiation in at least two types of central neurons: hippocam-
pal pyramidal neurons [13] and corticospinal motor neurons [30].
This receptor system is also involved in axonal regeneration in
adult peripheral nervous system [17], [18]. In fishes, adult CNS
neurons are able to regenerate throughout the entire life span, and
the IGF-1/PI3K system is also required [31]. The possible role of
this receptor/signaling pathway in the regeneration of axons in
adult central neurons has not yet been studied. In order to perform
these studies we chose RGCs as a model for mature neurons for
the following reasons: i) the axons of these cells, located in the optic
nerve, are affected in many disorders including traumatic optic
neuropathy [32], ischemic optic neuropathy [33], optic neuritis
[34] and glaucoma [35]. Functional recovery after these insults
requires overcoming several barriers compromising RGC axonal
outgrowth potential; ii) all the retinal neurons, including RGC, are
able to survive and develop neurites in primary cultures including
those from adult animals and humans [19], [23], [36]; iii) retinal
cells in culture have been extensively used to study the cellular and
molecular mechanisms involved in axonal regeneration [37], [38];
iv) retina cells express IGF and IGF-1R widely [20,21]; and v) the
optic nerve is a readily accessible region of the CNS in which to
further explore these studies in vivo.
The expression of IGF-1R is developmentally regulated in
brain, reaching highest levels at embryonic and early postnatal
stages [39], [40]. Expression of IGF-1R is relatively low in the
adult retina. We observed a significant increase in the expression
of this receptor after disaggregation and culture of adult RGC.
These results suggest that axon severing during disaggregation can
trigger IGF-1R re-expression as part of a ‘‘regeneration program’’.
The fact that polarized activation of the IGF-1R at the growth
cone and distal axon is sufficient to stimulate axonal regeneration
in the absence of any other growth factor is a novel observation.
This is somewhat in contradiction to the observation that CNS
neurons, using RGC as an experimental model, require a cocktail
of trophic factors in order to survive and regenerate neurites in vitro
[41]. We cannot rule out the secretion of additional trophic factors
by surrounding retinal cells in our culture model, but the loss-of-
function experiments using blocking IGF-1R antibody or shRNA
targeting IGF-1R demonstrate that the activation of IGF-1R is
essential for renewed axonal outgrowth in adult RGC. Previous
studies have shown that IGF-1 protects axotomized RGC from
Figure 3. Treatment with the PI3K inhibitor LY 294002 or the
IGF-1R blocking antibody aIR3 prevents axon formation in
adult RGC in culture. A) Double immunofluorescence showing the
distribution of the RGC marker NF200 and the axonal marker Tau-1 in
cultured adult RGC. Cells were cultured for 3 days in control conditions
or in the presence of 20 nM LY 294002 (LY) or aIR3 (10 mg/ml).
Calibration bar = 40 mm. B) Percentage (+/2 s.e.m.) of adult RGC
cultured for 3 days in the different conditions described above (Fig 3A),
exhibiting or lacking axons. n = 3 independent experiments. At least 100
cells were scored for each condition. * Significantly different from LY
and a IR3 p#0,0005. C) Cell viability (determined by the criterion of
propidium iodide exclusion [52]) after 1 or 4 DIV. n = 3 independent
experiments. At least 100 neurons were scored for each condition.
doi:10.1371/journal.pone.0054462.g003
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secondary death via PI3K dependent akt phosphorylation and
activation of caspase-3 in vivo [42]. IGF-1, IGF-1R and IGF
binding proteins, which modulate ligand availability and receptor
activation, are all found within the mammalian retina including
man [21]. It is of interest in the present context that IGF-1 mRNA
is localized to RGC cell bodies, whereas IGF-1R are more
widespread [20]. There is a notable down-regulation of endoge-
nous IGF-1 expression by the RGC during postnatal maturation
[43], which may be one of the reasons of the very limited axonal
regeneration in adult optic nerve. In keeping with this idea, IGF-1
delivery into postnatal rat eyes partly rescues RGC from
programmed cell death and maintains higher numbers of axons
within the optic nerve [44]. And IGF-1 is down-regulated rapidly
in RGC following optic nerve transection, leading to interruption
in PI3K signaling and RGC death [45]. Taken together with the
data presented here, this strongly suggests that the IGF-1/IGF1-
R/PI3K system is important for regulating both cell survival and
axonal regeneration in adult RGC.
Several neurotrophic factors have been implicated in amelio-
rating survival and axonal regeneration in adult RGC. Hepatocyte
Figure 4. Silencing IGF-1R expression prevents axonal formation in adult RGC in culture. A) Double immunofluorescence of adult RGC
after 3 days in culture transfected with scrambled sequence RNA (ssRNA) or shRNA directed to the IGF-1R (shRNA) showing the distribution of the
IGF-1R b subunit and the axonal marker Tau-1. GFP shows the efficiency of cell transfection. Calibration bar = 10 mm. B) Percentage (+/2 s.e.m.) of
adult RGC treated as described above (Fig. 4A) exhibiting or lacking axons. n = 3 independent experiments. At least 100 cells were scored for each
condition. * Significantly different from shRNA p#0,0005. C) Cell viability (determined by the criterion of propidium iodide exclusion [52]) after 4 DIV.
n = 3 independent experiments. At least 50 neurons were scored for each condition.
doi:10.1371/journal.pone.0054462.g004
Figure 5. Co-transfection of IGF-1R-suppressed adult RGC with a constitutively active form of the PI3k catalytic subunit p-110
restores the ability of the neurons to form axons. Double immunofluorescence of adult RGC showing the distribution of NF200 (displaying
neuronal shape) and myc (marker of transfection with cDNA encoding for a constitutively active form of the PI3K regulatory subunit p110). GFP is a
marker of transfection efficiency with the shRNA directed to IGF-1R. Cells were transfected and cultured for 4 days. Calibration bar = 10 mm.
doi:10.1371/journal.pone.0054462.g005
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growth factor improves both RGC survival and axonal regener-
ation in vivo and in vitro, and also exerts its effects through
activation of Akt [46]. Similarly, BDNF administration to adult
RGC in vitro stimulates neurite outgrowth through the PI3K
pathway [47]. Fibroblast growth factors (FGFs) probably play
multiple roles in RGC survival and process growth, since in vitro
studies showed that FGF-2 and FGF-9 stimulate adult RGC
survival without affecting axon extension [24] while studies in vivo
demonstrated that stimulation of axon growth in adult RGC by
FGF-2 depends on the activation of the extracellular signal-
regulated kinase 1/2 but not PI3K [48], [49]. Although there are
numerous similarities between axon outgrowth in embryonic and
adult CNS, there are also some differences. While BDNF (acting
through the PI3K pathway) has been shown to be involved in
adult RGC process regeneration [47], this factor does not trigger
axonal specification and outgrowth in embryonic hippocampal
neurons [13] or cortical motor neurons [30].
The results shown here indicate that PI3K activation is
necessary for the activated IGF-1R induction of RGC axonal
regeneration. Moreover, transfection with a constitutively active
form of PI3K was sufficient to trigger axonal regeneration in the
absence of any other extracellular stimulus. It has also been shown
that PI3K activation significantly increases axonal regeneration
over the level induced by pten (phosphatase and tensin homolog)
deletion [50]. This could be very interesting in the field of gene
therapy directed towards promotion of re-growth of damaged
RGC axons in several neurodegenerative conditions. This is
especially cogent given that up-regulation of IGF-1 within the eye
leads to appearance of diabetes-like alterations [51], which
cautions against direct use of this growth factor in promoting
axonal repair.
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